Literature DB >> 3376744

Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine.

E Bäckman1, A Bengtsson, M Bengtsson, C Lennmarken, K G Henriksson.   

Abstract

Muscle fatigue is the most disabling symptom in primary fibromyalgia (PF), which in addition is characterized by generalised pain and muscle stiffness. In order to assess whether the fatigue is of central and/or peripheral origin, skeletal muscle function was studied by measuring maximum voluntary hand grip strength, and by measuring various contraction characteristics in the adductor pollicis muscle after electrical stimulation of the ulnar nerve. The PF-patients were also studied after a regional sympathetic blockade of the forearm with guanethidine. A lower hand grip strength was found in the PF-patients compared to the controls, before as well as during the sympathetic blockade. The developed force, measured during electrical stimulation, did not differ between patients and controls. A lower muscle relaxation rate was found in the PF-patients. The relaxation rate increased in the PF-patients during the sympathetic blockade. The results indicate both a central and a peripheral cause of muscle dysfunction. Activity in the muscle sympathetic system may be one link in the chain of events that leads to muscular symptoms in PF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3376744     DOI: 10.1111/j.1600-0404.1988.tb05893.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

Review 1.  Sympathetic nervous system function in fibromyalgia.

Authors:  F Petzke; D J Clauw
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

2.  Experimental muscle pain changes motor control strategies in dynamic contractions.

Authors:  Ulysses F Ervilha; Dario Farina; Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2005-06-11       Impact factor: 1.972

3.  [Pharmacological treatment of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Berliner; W Brückle; S Ehlers; K Mönkemöller; B Moradi; F Petzke; N Uçeyler; R Wörz; E Winter; D O Nutzinger
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

4.  Progress in Sympathetically Mediated Pathological Pain.

Authors:  Si-Si Chen; Jun-Ming Zhang
Journal:  J Anesth Perioper Med       Date:  2015-06-06

5.  Urinary albumin, protein excretion and circadian blood pressure in patients with fibromyalgia.

Authors:  Baris Afsar; Rukuye Burucu
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

6.  The effect of muscle pain on elbow flexion and coactivation tasks.

Authors:  Ulysses F Ervilha; Lars Arendt-Nielsen; Marcos Duarte; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2004-01-28       Impact factor: 1.972

Review 7.  Impact of clinical and experimental pain on muscle strength and activity.

Authors:  Thomas Graven-Nielsen; Lars Arendt-Nielsen
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

8.  Exercise prevents development of autonomic dysregulation and hyperalgesia in a mouse model of chronic muscle pain.

Authors:  Rasna Sabharwal; Lynn Rasmussen; Kathleen A Sluka; Mark W Chapleau
Journal:  Pain       Date:  2016-02       Impact factor: 7.926

9.  Heart rate turbulence analysis in female patients with fibromyalgia.

Authors:  Huseyin Dursun; Ersel Onrat; Emine Ercan; Umit Secil Demirdal; Alaettin Avsar; Umit Dundar; Ozlem Solak; Hasan Toktas
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

10.  Treatment options and patient perspectives in the management of fibromyalgia: future trends.

Authors:  Kim Lawson
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.